{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:52:11Z","timestamp":1789980731934,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s40263-017-0436-x","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T14:27:28Z","timestamp":1495204048000},"page":"483-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-8073","authenticated-orcid":false,"given":"Yen-Hao","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina C. M.","family":"Schuiling-Veninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorieke E. H.","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"key":"436_CR1","volume-title":"Endotext","author":"B Ergun-Longmire","year":"2000","unstructured":"Ergun-Longmire B, Maclaren NK. Etiology and pathogenesis of diabetes mellitus in children. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext. South Dartmouth: MDText.com, Inc.; 2000."},{"issue":"1","key":"436_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.12r07922","volume":"74","author":"F Rotella","year":"2013","unstructured":"Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry. 2013;74(1):31\u20137.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"436_CR3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/YIC.0b013e3282202c0e","volume":"22","author":"MJ Knol","year":"2007","unstructured":"Knol MJ, Geerlings MI, Egberts AC, Gorter KJ, Grobbee DE, Heerdink ER. No increased incidence of diabetes in antidepressant users. Int Clin Psychopharmacol. 2007;22(6):382\u20136.","journal-title":"Int Clin Psychopharmacol."},{"issue":"1","key":"436_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00125-011-2268-4","volume":"55","author":"A Pan","year":"2012","unstructured":"Pan A, Sun Q, Okereke OI, Rexrode KM, Rubin RR, Lucas M, et al. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia. 2012;55(1):63\u201372.","journal-title":"Diabetologia"},{"issue":"1","key":"436_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.13m08421","volume":"75","author":"CS Wu","year":"2014","unstructured":"Wu CS, Gau SS, Lai MS. Long-term antidepressant use and the risk of type 2 diabetes mellitus: a population-based, nested case\u2013control study in Taiwan. J Clin Psychiatry. 2014;75(1):31\u20138 (quiz 8).","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"436_CR6","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/dc13-2642","volume":"37","author":"VG Vimalananda","year":"2014","unstructured":"Vimalananda VG, Palmer JR, Gerlovin H, Wise LA, Rosenzweig JL, Rosenberg L, et al. Depressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women\u2019s Health Study. Diabetes Care. 2014;37(8):2211\u20137.","journal-title":"Diabetes Care."},{"issue":"5","key":"436_CR7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/appi.ajp.2008.08071065","volume":"166","author":"F Andersohn","year":"2009","unstructured":"Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry. 2009;166(5):591\u20138.","journal-title":"Am J Psychiatry."},{"issue":"7","key":"436_CR8","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/gps.2409","volume":"25","author":"E Atlantis","year":"2010","unstructured":"Atlantis E, Browning C, Sims J, Kendig H. Diabetes incidence associated with depression and antidepressants in the Melbourne Longitudinal Studies on Healthy Ageing (MELSHA). Int J Geriatr Psychiatry. 2010;25(7):688\u201396.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"9","key":"436_CR9","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00228-011-1168-3","volume":"68","author":"S Khoza","year":"2012","unstructured":"Khoza S, Barner JC, Bohman TM, Rascati K, Lawson K, Wilson JP. Use of antidepressant agents and the risk of type 2 diabetes. Eur J Clin Pharmacol. 2012;68(9):1295\u2013302.","journal-title":"Eur J Clin Pharmacol."},{"issue":"2","key":"436_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.diabres.2014.04.016","volume":"105","author":"R Bhattacharya","year":"2014","unstructured":"Bhattacharya R, Ajmera M, Bhattacharjee S, Sambamoorthi U. Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults. Diabetes Res Clin Pract. 2014;105(2):251\u201360.","journal-title":"Diabetes Res Clin Pract."},{"issue":"23","key":"436_CR11","doi-asserted-by":"crossref","first-page":"e919","DOI":"10.1097\/MD.0000000000000919","volume":"94","author":"KJ Chang","year":"2015","unstructured":"Chang KJ, Hong CH, Lee Y, Lee KS, Roh HW, Back JH, et al. Effect of psychotropic drugs on development of diabetes mellitus in patients with Alzheimer\u2019s disease. Medicine (Baltimore). 2015;94(23):e919.","journal-title":"Medicine (Baltimore)."},{"issue":"5","key":"436_CR12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1176\/appi.ajp.2009.09010038","volume":"167","author":"A Campayo","year":"2010","unstructured":"Campayo A, de Jonge P, Roy JF, Saz P, de la Camara C, Quintanilla MA, et al. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry. 2010;167(5):580\u20138.","journal-title":"Am J Psychiatry."},{"issue":"3","key":"436_CR13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/1753-0407.12014","volume":"5","author":"U Sambamoorthi","year":"2013","unstructured":"Sambamoorthi U, Ma Y, Findley PA, Rust G. Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries. J Diabetes. 2013;5(3):327\u201335.","journal-title":"J Diabetes."},{"issue":"1","key":"436_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14740338.5.1.157","volume":"5","author":"RS McIntyre","year":"2006","unstructured":"McIntyre RS, Soczynska JK, Konarski JZ, Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf. 2006;5(1):157\u201368.","journal-title":"Expert Opin Drug Saf."},{"issue":"12","key":"436_CR15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s40263-013-0115-5","volume":"27","author":"K Weston-Green","year":"2013","unstructured":"Weston-Green K, Huang XF, Deng C. Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor. CNS Drugs. 2013;27(12):1069\u201380.","journal-title":"CNS Drugs."},{"issue":"5","key":"436_CR16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.jcp.0000239789.83707.7d","volume":"26","author":"RD Jindal","year":"2006","unstructured":"Jindal RD, Keshavan MS. Critical role of M3 muscarinic receptor in insulin secretion: implications for psychopharmacology. J Clin Psychopharmacol. 2006;26(5):449\u201350.","journal-title":"J Clin Psychopharmacol."},{"issue":"3","key":"436_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erp.13.20","volume":"13","author":"ST Visser","year":"2013","unstructured":"Visser ST, Schuiling-Veninga CC, Bos JH, de Jong-van den Berg LT, Postma MJ. The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res. 2013;13(3):285\u201392.","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"issue":"4","key":"436_CR18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/diaspect.24.4.234","volume":"24","author":"A Rehman","year":"2011","unstructured":"Rehman A, Setter SM, Vue MH. Drug-induced glucose alterations. Part 2: drug-induced hyperglycemia. Diabetes Spectr. 2011;24(4):234.","journal-title":"Diabetes Spectr."},{"issue":"2","key":"436_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-G","volume":"45","author":"M Korff Von","year":"1992","unstructured":"Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45(2):197\u2013203.","journal-title":"J Clin Epidemiol."},{"issue":"5","key":"436_CR20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047\u201353.","journal-title":"Diabetes Care."},{"key":"436_CR21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40200-015-0164-z","volume":"14","author":"SI Okoduwa","year":"2015","unstructured":"Okoduwa SI, Umar IA, Ibrahim S, Bello F, Habila N. Age-dependent alteration of antioxidant defense system in hypertensive and type-2 diabetes patients. J Diabetes Metab Disord. 2015;14:32.","journal-title":"J Diabetes Metab Disord."},{"issue":"4","key":"436_CR22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2337\/dc09-1663","volume":"33","author":"P Demakakos","year":"2010","unstructured":"Demakakos P, Pierce MB, Hardy R. Depressive symptoms and risk of type 2 diabetes in a national sample of middle-aged and older adults: the English longitudinal study of aging. Diabetes Care. 2010;33(4):792\u20137.","journal-title":"Diabetes Care."},{"issue":"6","key":"436_CR23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCGENETICS.114.000676","volume":"7","author":"KH Chan","year":"2014","unstructured":"Chan KH, Huang YT, Meng Q, Wu C, Reiner A, Sobel EM, et al. Shared molecular pathways and gene networks for cardiovascular disease and type 2 diabetes mellitus in women across diverse ethnicities. Circ Cardiovasc Genet. 2014;7(6):911\u20139.","journal-title":"Circ Cardiovasc Genet."},{"issue":"6","key":"436_CR24","first-page":"414","volume":"31","author":"P Chokka","year":"2006","unstructured":"Chokka P, Tancer M, Yeragani VK. Metabolic syndrome: relevance to antidepressant treatment. J Psychiatry Neurosci. 2006;31(6):414.","journal-title":"J Psychiatry Neurosci."},{"issue":"11","key":"436_CR25","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/0006-2952(93)90211-E","volume":"45","author":"T Stanton","year":"1993","unstructured":"Stanton T, Bolden-Watson C, Cusack B, Richelson E. Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics. Biochem Pharmacol. 1993;45(11):2352\u20134.","journal-title":"Biochem Pharmacol."},{"issue":"11","key":"436_CR26","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/jcph.151","volume":"53","author":"L An","year":"2013","unstructured":"An L, Ravindran PP, Renukunta S, Denduluri S. Co-medication of pravastatin and paroxetine\u2014a categorical study. J Clin Pharmacol. 2013;53(11):1212\u20139.","journal-title":"J Clin Pharmacol."},{"issue":"2","key":"436_CR27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2174\/1574886309666140527112907","volume":"10","author":"KM Gooden","year":"2015","unstructured":"Gooden KM, Bibeau KB, Wood J, Irizarry MC, Pan X, Allen J, et al. Incidence of type 2 diabetes among patients exposed to the combination of pravastatin and paroxetine. Curr Drug Saf. 2015;10(2):152\u20138.","journal-title":"Curr Drug Saf."},{"issue":"6","key":"436_CR28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/aps.2014.24","volume":"35","author":"F Li","year":"2014","unstructured":"Li F, Zhang M, Xu D, Liu C, Zhong ZY, Jia LL, et al. Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure. Acta Pharmacol Sin. 2014;35(6):792\u2013805.","journal-title":"Acta Pharmacol Sin."},{"issue":"3","key":"436_CR29","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2337\/db12-0789","volume":"62","author":"D Gero","year":"2013","unstructured":"Gero D, Szoleczky P, Suzuki K, Modis K, Olah G, Coletta C, et al. Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction. Diabetes. 2013;62(3):953\u201364.","journal-title":"Diabetes."},{"issue":"3","key":"436_CR30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1254\/jphs.FP0071049","volume":"105","author":"K Hamada","year":"2007","unstructured":"Hamada K, Yoshida M, Isayama H, Yagi Y, Kanazashi S, Kashihara Y, et al. Possible involvement of endogenous 5-HT in aggravation of cerulein-induced acute pancreatitis in mice. J Pharmacol Sci. 2007;105(3):240\u201350.","journal-title":"J Pharmacol Sci."},{"issue":"1\u20133","key":"436_CR31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2013.02.023","volume":"146","author":"MD Guenette","year":"2013","unstructured":"Guenette MD, Giacca A, Hahn M, Teo C, Lam L, Chintoh A, et al. Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: an animal model. Schizophr Res. 2013;146(1\u20133):162\u20139.","journal-title":"Schizophr Res."},{"key":"436_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.peptides.2015.07.008","volume":"71","author":"H Bennet","year":"2015","unstructured":"Bennet H, Balhuizen A, Medina A, Dekker Nitert M, Ottosson Laakso E, Essen S, et al. Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes. Peptides. 2015;71:113\u201320.","journal-title":"Peptides."},{"issue":"7","key":"436_CR33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2002.12.001","volume":"57","author":"E Schirm","year":"2004","unstructured":"Schirm E, Tobi H, de Jong-van den Berg LT. Identifying parents in pharmacy data: a tool for the continuous monitoring of drug exposure to unborn children. J Clin Epidemiol. 2004;57(7):737\u201341.","journal-title":"J Clin Epidemiol."},{"key":"436_CR34","unstructured":"McCulloch DK. Initial management of blood glucose in adults with type 2 diabetes mellitus. UpToDate\u00ae 2017. https:\/\/www.uptodate.com\/contents\/initial-management-of-blood-glucose-in-adults-with-type-2-diabetes-mellitus . Accessed 31 Mar 2017."},{"key":"436_CR35","unstructured":"McCulloch DK. Metformin in the treatment of adults with type 2 diabetes mellitus. UpToDate\u00ae 2017. https:\/\/www.uptodate.com\/contents\/metformin-in-the-treatment-of-adults-with-type-2-diabetes-mellitus . Accessed 31 Mar 2017."},{"key":"436_CR36","unstructured":"The Metabolomics Innovation Centre. DrugBank. Muscarinic acetylcholine receptor M3. https:\/\/www.drugbank.ca\/biodb\/polypeptides\/P20309 . Accessed 31 Mar 2017."},{"key":"436_CR37","unstructured":"Birdsall NJM, Brown DA, Buckley NJ, et al. Acetylcholine receptors (muscarinic): M3 receptor. IUPHAR\/BPS guide to pharmacology. http:\/\/www.guidetopharmacology.org\/GRAC\/ObjectDisplayForward?objectId=15 . Accessed 05 Aug 2015."},{"key":"436_CR38","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health. DDD: definition and general considerations. http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/ . Accessed 8 May 2017."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-017-0436-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-017-0436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-017-0436-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:52:44Z","timestamp":1719211964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-017-0436-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["436"],"URL":"https:\/\/doi.org\/10.1007\/s40263-017-0436-x","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,19]]}}}